Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05349422 · ClinicalTrials.gov registry record · NA

Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care

A NA study of Blood Pressure and Medication Adherence, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
1,726
Enrollment target
1
Study location

NCT05349422 is a NA study of Blood Pressure and Medication Adherence that has completed, run by NYU Langone Health. The registered enrollment target is 1,726 participants, above the 270-participant average among 101 other Blood Pressure trials with a reported enrollment target (539% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05349422, a NA study of Blood Pressure and Medication Adherence, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
1,726 participants
Enrollment target
1
Study location

Study Summary

The study team will conduct a cluster randomized control trial in 10 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherence and blood pressure control for patients who are non-adherent to antihypertensive medications.

Interventions

  • BEHAVIORAL Electronic Health Record (EHR) Enabled Teamlets

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 1,726 participants
Start Date 2022-10-06
Est. Completion 2025-05-11
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05349422

The ClinicalTrials.gov registry entry for NCT05349422 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,726 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 270-participant average among 101 other Blood Pressure trials with a reported enrollment target (539% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Electronic Health Record (EHR) Enabled Teamlets is the first listed.

NCT05349422 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05349422 about?

NCT05349422 is a clinical study titled "Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care". The study team will conduct a cluster randomized control trial in 10 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherence and blood pressure control for patients who are non-adherent to antihypertensive medications.

What is the current status of trial NCT05349422?

This trial is currently completed. It is a NA study. The enrollment target is 1,726 participants. The study started on 2022-10-06. Estimated completion is 2025-05-11.

What conditions does trial NCT05349422 study?

This clinical trial studies the following conditions: Blood Pressure, Medication Adherence.

What interventions are being tested in trial NCT05349422?

The interventions under investigation include: Electronic Health Record (EHR) Enabled Teamlets (BEHAVIORAL).

Who is sponsoring clinical trial NCT05349422?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05349422 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.